Endometrial Cancer Trial, Recruiting NCT06656949 Sponsor: Qilu Hospital of Shandong University Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT06656949
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 80 years old
  • People who have been diagnosed with epithelial ovarian cancer (a specific type of ovarian cancer confirmed by laboratory testing)
  • People whose doctors expect them to live for more than 3 months
  • People who are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • People who have had a heart attack, stroke, unstable chest pain, or serious heart failure
  • People with a history of exhaustion-related conditions or deep vein thrombosis (blood clots in the veins) (confirm with trial site)
  • People whose liver is not working well, specifically where certain liver enzyme levels are more than 2.5 times the accepted upper normal range
  • People whose kidneys are not working well, specifically where certain kidney-related blood levels are more than 2 times the accepted upper normal range
  • People who are pregnant or in the period around childbirth
  • People who have had a major organ transplant or have a history of immune system disease
  • People with a psychiatric condition or significant language barriers that would affect participation
  • People with a current or past history of alcohol or drug misuse
  • People who are unable or unwilling to sign the consent form or follow the study requirements
  • People who have been diagnosed with another type of cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-18560088205

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Qilu Hospital of Shandong University
Registry
ClinicalTrials.gov
Start date
30 October 2024
Est. completion
30 October 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

paraaortic Sentinel lymph node detection rates; Sentinel lymph node technique accuracy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov